The evolving haemophilia care landscape has evolved with personalised prophylaxis, new coagulation factor molecules, non-replacement therapies, and gene therapy, leading to significantly reduced bleeding frequency and haemophilic arthropathy burden. With improved treatment outcomes, clinical priorities have shifted from bleed prevention to long-term joint preservation and enhanced quality of life for people with haemophilia (PwH). Subclinical joint changes often go undetected without sensitive tools. To this end, point-of-care musculoskeletal ultrasound (POC MCK-US) has emerged as a crucial way for early detection of joint abnormalities offering fast, non-invasive, and repeatable assessments. When embedded within a structured multidisciplinary team, POC MSK-US facilitates real-time, personalised decision-making and enhances cross-disciplinary communication. In addition, it provides valuable information to patients and caregivers about their joint health and prophylaxis success, improving patient adherence and self-efficacy. Broader adoption of POC MSK-US remains limited due to access to training, equipment, and standardised assessment frameworks. Promoting its implementation through interprofessional education, standardisation, and institutional support—particularly via societies like the European Association for Haemophilia and Allied Disorders (EAHAD)—will be key to expanding equitable access, improving patient outcomes, and ensuring comprehensive, proactive haemophilia management.
A Common Language for the Multidisciplinary Team: Point‐of‐Care Musculoskeletal Ultrasound in Modern Haemophilia Care / H. De La Corte‐rodriguez, M.T.Á.. - In: HAEMOPHILIA. - ISSN 1351-8216. - (2026). [Epub ahead of print] [10.1111/hae.70411]
A Common Language for the Multidisciplinary Team: Point‐of‐Care Musculoskeletal Ultrasound in Modern Haemophilia Care
R. Gualtierotti
;
2026
Abstract
The evolving haemophilia care landscape has evolved with personalised prophylaxis, new coagulation factor molecules, non-replacement therapies, and gene therapy, leading to significantly reduced bleeding frequency and haemophilic arthropathy burden. With improved treatment outcomes, clinical priorities have shifted from bleed prevention to long-term joint preservation and enhanced quality of life for people with haemophilia (PwH). Subclinical joint changes often go undetected without sensitive tools. To this end, point-of-care musculoskeletal ultrasound (POC MCK-US) has emerged as a crucial way for early detection of joint abnormalities offering fast, non-invasive, and repeatable assessments. When embedded within a structured multidisciplinary team, POC MSK-US facilitates real-time, personalised decision-making and enhances cross-disciplinary communication. In addition, it provides valuable information to patients and caregivers about their joint health and prophylaxis success, improving patient adherence and self-efficacy. Broader adoption of POC MSK-US remains limited due to access to training, equipment, and standardised assessment frameworks. Promoting its implementation through interprofessional education, standardisation, and institutional support—particularly via societies like the European Association for Haemophilia and Allied Disorders (EAHAD)—will be key to expanding equitable access, improving patient outcomes, and ensuring comprehensive, proactive haemophilia management.| File | Dimensione | Formato | |
|---|---|---|---|
|
Haemophilia - 2026 - De la Corte‐Rodriguez - A Common Language for the Multidisciplinary Team Point‐of‐Care.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
587.95 kB
Formato
Adobe PDF
|
587.95 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




